Healthy subject
Conditions
Interventions
Sponsors
TTC Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Japanese male and female whose age is between 45 and 70 years old 2. Subjects whose BMI is between 23 and 30
Exclusion criteria
Exclusion criteria: 1. Subjects who are currently under medical treatment, diet therapy or exercise therapy. 2. Subjects who are under treatment or have a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease, abnormal secretion disease of adrenocortical hormone) 3. Subjects with allergies to the test food in this study 4. Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period. 5. Subjects who routinely use some medicine, health foods affecting body fat or lipid metabolism. 6. Subjects who currently are dieting. 7. Subjects who have participated in other clinical study within the past month prior. 8. Subjects who use some medicine, food containing lactic acid bacteria or polymethoxyflavone 3 days a week or more from half a year before the informed consent. 9. Subjects who are judges as unsuitable for the study based on the results of lifestyle questionnaire 10. Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or cardiopulmonary function. 11. Subjects who have diseases requiring continuous medication, or serious medical history who needed medication therapy 12. Subjects who always use laxative when defecation. 13. Subjects who have taken antibiotics within the past month 14. Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or physical examination. 15. Subjects who are planning to travel abroad during the study period, or who are planning of long term domestic trip for more than one week in study period. 16. Subjects who are judged as unsuitable for the study by the investigator for other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal visceral fat area | — |
Secondary
| Measure | Time frame |
|---|---|
| Abdominal total fat area, abdominal subcutaneous fat area, body weight, BMI, waist circumference, hip circumference, ratio of waist and hip circumferences, subgroup analysis (BMI, abdominal visceral fat area, sex, defecation frequency) | — |
Countries
Japan
Contacts
Public ContactShingo Yamamichi
TTC Co., Ltd. Clinical Research Planning Department
Outcome results
None listed